alibaba health information tech - ALBBY

ALBBY

Close Chg Chg %
8.67 0.39 4.44%

Closed Market

9.06

+0.39 (4.44%)

Volume: 1.48K

Last Updated:

Dec 19, 2024, 3:37 PM EDT

Company Overview: alibaba health information tech - ALBBY

ALBBY Key Data

Open

$8.79

Day Range

8.79 - 9.06

52 Week Range

6.88 - 15.65

Market Cap

$7.10B

Shares Outstanding

803.96M

Public Float

N/A

Beta

0.66

Rev. Per Employee

N/A

P/E Ratio

40.88

EPS

N/A

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.38K

 

ALBBY Performance

1 Week
 
-2.00%
 
1 Month
 
0.11%
 
3 Months
 
19.14%
 
1 Year
 
-28.08%
 
5 Years
 
N/A
 

ALBBY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About alibaba health information tech - ALBBY

Alibaba Health Information Technology Ltd. is an investment holding company, which engages in the provision of Internet technology, service tools, and platforms to offer medical and healthcare services. Its activities include self-operated healthcare product sales, e-commerce platform services, tracking services, and innovative healthcare related services and others. The company was founded on March 11, 1998 and is headquartered in Hong Kong.

ALBBY At a Glance

Alibaba Health Information Technology Ltd.
26/F, Tower One
Hong Kong,
Phone 852-2583-9333 Revenue 3.77B
Industry Information Technology Services Net Income 123.20M
Sector Technology Services Employees 1,435
Fiscal Year-end 03 / 2025
View SEC Filings

ALBBY Valuation

P/E Current 40.88
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 46.302
Price to Sales Ratio 1.519
Price to Book Ratio 3.242
Price to Cash Flow Ratio 31.07
Enterprise Value to EBITDA 45.527
Enterprise Value to Sales 1.16
Total Debt to Enterprise Value 0.003

ALBBY Efficiency

Revenue/Employee 2,626,323.148
Income Per Employee 85,852.455
Receivables Turnover 34.693
Total Asset Turnover 1.312

ALBBY Liquidity

Current Ratio 2.689
Quick Ratio 2.41
Cash Ratio 1.956

ALBBY Profitability

Gross Margin 21.813
Operating Margin 2.35
Pretax Margin 3.498
Net Margin 3.269
Return on Assets 4.288
Return on Equity 5.838
Return on Total Capital 6.088
Return on Invested Capital 5.821

ALBBY Capital Structure

Total Debt to Total Equity 0.565
Total Debt to Total Capital 0.562
Total Debt to Total Assets 0.417
Long-Term Debt to Equity 0.33
Long-Term Debt to Total Capital 0.328
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alibaba Health Information Tech - ALBBY

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.29B 3.21B 3.90B 3.77B
Sales Growth
+66.17% +40.09% +21.74% -3.45%
Cost of Goods Sold (COGS) incl D&A
1.76B 2.57B 3.07B 2.95B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.88M 9.44M 9.29M 7.49M
Depreciation
4.58M 7.58M 6.74M 5.12M
Amortization of Intangibles
296.91K 1.86M 2.55M 2.36M
COGS Growth
+44.50% +46.21% +19.70% -4.08%
Gross Income
533.52M 640.14M 831.57M 822.09M
Gross Income Growth
+228.03% +19.98% +29.90% -1.14%
Gross Profit Margin
+23.31% +19.96% +21.30% +21.81%
2021 2022 2023 2024 5-year trend
SG&A Expense
523.87M 810.71M 838.15M 733.53M
Research & Development
62.48M 113.57M 98.86M 98.36M
Other SG&A
461.39M 697.14M 739.29M 635.17M
SGA Growth
+207.33% +54.75% +3.38% -12.48%
Other Operating Expense
- - - 2.12M
-
Unusual Expense
(8.01M) (24.62M) (4.07M) 49.72M
EBIT after Unusual Expense
15.54M (145.95M) (2.51M) 38.84M
Non Operating Income/Expense
49.66M 114.31M 82.07M 93.82M
Non-Operating Interest Income
24.40M 32.70M 48.36M 67.50M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
361.21K 594.48K 850.78K 832.36K
Interest Expense Growth
-88.54% +64.58% +43.11% -2.16%
Gross Interest Expense
361.21K 594.48K 850.78K 832.36K
Interest Capitalized
- - - -
-
Pretax Income
64.84M (32.24M) 78.71M 131.82M
Pretax Income Growth
+947.51% -149.72% +344.12% +67.49%
Pretax Margin
+2.83% -1.01% +2.02% +3.50%
Income Tax
8.63M 2.09M 2.44M 7.85M
Income Tax - Current - Domestic
5.80M 5.38M 4.55M 11.80M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
2.84M (3.29M) (2.11M) (3.96M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
50.54M (41.44M) 77.93M 123.15M
Minority Interest Expense
(871.39K) (60.15K) 124.85K (47.55K)
Net Income
51.41M (41.38M) 77.80M 123.20M
Net Income Growth
+5,538.77% -180.48% +288.01% +58.35%
Net Margin Growth
+2.25% -1.29% +1.99% +3.27%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
51.41M (41.38M) 77.80M 123.20M
Preferred Dividends
- - - -
-
Net Income Available to Common
51.41M (41.38M) 77.80M 123.20M
EPS (Basic)
0.0776 -0.0614 0.1152 0.1755
EPS (Basic) Growth
+4,950.00% -179.12% +287.62% +52.34%
Basic Shares Outstanding
662.29M 674.13M 675.15M 702.20M
EPS (Diluted)
0.0772 -0.0614 0.1149 0.1749
EPS (Diluted) Growth
+4,925.00% -179.53% +287.13% +52.22%
Diluted Shares Outstanding
666.33M 674.13M 677.08M 704.53M
EBITDA
12.41M (161.13M) 2.71M 96.04M
EBITDA Growth
+443.86% -1,398.92% +101.68% +3,442.03%
EBITDA Margin
+0.54% -5.03% +0.07% +2.55%

Alibaba Health Information Tech in the News